Lineage price target lowered to $40 from $53 at Truist

Truist lowered the firm’s price target on Lineage (LINE) to $40 from $53 and keeps a Buy rating on the shares. The firm, which is lowering its earnings estimates, largely due to more conservative assumed throughput and value of handled items, expects 2026 to mark trough earnings and calls valuation “undemanding” after the stock’s 42% year-to-date pullback.